Heather Roxborough
Senior Partner, Head of HealthTech
Heather leads OSE’s HealthTech investment team, overseeing venture building, investments and portfolio across digital health, diagnostics, medical devices and life science tools.
She has more than 20 years of experience in healthcare innovation and venture investing. Her first role was operational, leading a team at Unilever responsible for translating transformational science conducted in global research centres into radical new healthtech businesses. She made the jump to venture investing while at Unilever, subsequently transitioning to investment positions in both institutional and strategic funds. This included a role at Johnson & Johnson where she was responsible for consumer healthtech investments and partnering activities across EMEA.
Prior to joining OSE in 2022, Heather was a Partner at Optum Ventures, where she established and led its Global HealthTech investment fund on behalf of UnitedHealth Group.
Heather holds a PhD in Clinical Biochemistry from Queen’s University Belfast.
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting spinouts?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.